The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: A literature-based economic analysis

The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: A literature-based economic analysis

Jennifer Stephens, Kimbach Tran Carpiuc, Marc BottemanPharmerit North America LLC, Bethesda, MD, USAObjectives: To develop an economic analysis of the management of pleural effusions in patients with imatinib-resistant/intolerant chronic myelogenous leukemia (CML).Methods: A cost of treatment analys...

Full description

Bibliographic Details
Main Authors:	Jennifer Stephens, Kimbach Tran Carpiuc, Marc Botteman
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-12-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/the-burden-of-managing-pleural-effusions-in-patients-with-chronic-myel-a3863

Similar Items

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011-03-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

Imatinib-induced pleural effusion: A case report
by: R Banka, et al.
Published: (2017-01-01)

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia
by: Camillo Porta, et al.
Published: (2011-12-01)

Investigation of the mechanism of resistance to imatinib in chronic myelogenous leukemia at middle Taiwan
by: Chan-Yarn, et al.

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013-08-01)

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
by: Giovanni Martinelli, et al.
Published: (2009-02-01)

Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report
by: Scheid Christoph, et al.
Published: (2011-05-01)

Massive pericardial effusion and pleural effusion: cardiac and pleural infiltration in newly diagnosed acute myeloid leukemia
by: Tao Ma, et al.
Published: (2021-09-01)

Prognostic factors associated with complete cytogenetic response in patients with chronic myelogenous leukemia on imatinib mesylate therapy
by: Ćojbašić Irena, et al.
Published: (2010-01-01)

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.
by: Jaroslav Jelinek, et al.
Published: (2011-01-01)

Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells
by: Viviana De Rosa, et al.
Published: (2019-06-01)

Real-time analysis of imatinib- and dasatinib-induced effects on chronic myelogenous leukemia cell interaction with fibronectin.
by: Adam Obr, et al.
Published: (2014-01-01)

Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
by: Ladislav Chrobák, et al.
Published: (2003-01-01)

Imatinib as a Dominant Therapeutic Strategy in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach
by: Ballard, Erin Elissa
Published: (2004)

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
by: Kodama Yuko, et al.
Published: (2012-04-01)

Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey
by: Kodama, Yuko
Published: (2017)

Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.
by: Clemens Woywod, et al.
Published: (2017-01-01)

Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin
by: The Staff
Published: (2014-01-01)

Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin.
Published: (2014-01-01)

THE SCREENING FOR SINGLE NUCLEOTIDE POLYMORPHISMS OF CYP3A4 IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS RECEIVING IMATINIB
by: Lamprecht, G A
Published: (2010)

Hematopathologic and cytogenetic findings in imatinib mesylate treated chronic myelogenous leukemia patients: 2.5 years' experience
by: Ćojbašić Irena, et al.
Published: (2010-01-01)

Extramedullary Acute Myeloid Leukemia (AML): Leukemic Pleural Effusion, Case Report and Review of the Literature
by: Naveen ePemmaraju, et al.
Published: (2014-06-01)

Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
by: Wang Sing-Ting, et al.
Published: (2021-03-01)

Pleural manometry in pleural effusion
by: Mohamed Galal, et al.
Published: (2016-04-01)

Pleural effusion
by: Mariia A. Karnaushkina, et al.
Published: (2019-03-01)

Chronic myelogenous leukemia in Libya
by: Itrat Mehdi, et al.
Published: (2012-07-01)

Chronic myelogenous leukemia on target
by: Veronika Némethová, et al.
Published: (2018-07-01)

Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature
by: Rohit Gulati, et al.
Published: (2015-01-01)

Immunoglobulin D multiple myeloma, plasma cell leukemia and chronic myelogenous leukemia in a single patient treated simultaneously with lenalidomide, bortezomib, dexamethasone and imatinib
by: Naveed Ali, et al.
Published: (2016-03-01)

Oroxyloside A Overcomes Bone Marrow Microenvironment-Mediated Chronic Myelogenous Leukemia Resistance to Imatinib via Suppressing Hedgehog Pathway
by: Xiaobo Zhang, et al.
Published: (2017-08-01)

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
by: Shovik Bandyopadhyay, et al.
Published: (2017-01-01)

Pleural effusion following ventriculo-pleural shunt: Case reports and review of the literature
by: Kupeli Elif, et al.
Published: (2010-01-01)

Pancreatic pleural effusion masquerading as right sided tubercular pleural effusion
by: Gopal Chawla, et al.
Published: (2019-09-01)

Tuberculose pleural Tuberculous pleural effusions
by: Márcia Seiscento, et al.
Published: (2006-08-01)

Myelomatous Pleural Effusion : Case report and review of the literature
by: Khalil Al-Farsi, et al.
Published: (2011-08-01)

An unusual cause of pleural effusion in a patient with heart failure
by: Daniel Bruno Takizawa, et al.